These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 21719764

  • 21. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G.
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [Abstract] [Full Text] [Related]

  • 22. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 May; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

  • 23. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ.
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [Abstract] [Full Text] [Related]

  • 24. DWI-ASPECTS as a predictor of dramatic recovery after intravenous recombinant tissue plasminogen activator administration in patients with middle cerebral artery occlusion.
    Aoki J, Kimura K, Shibazaki K, Sakamoto Y.
    Stroke; 2013 Feb; 44(2):534-7. PubMed ID: 23212169
    [Abstract] [Full Text] [Related]

  • 25. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G, Apoil M, Naggara O, Calvet D, Lamy C, Tataru AM, Méder JF, Mas JL, Baron JC, Oppenheim C, Touzé E.
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [Abstract] [Full Text] [Related]

  • 26. Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M, Mori M, Nezu T, Makihara N, Koga M, Okada Y, Minematsu K, Toyoda K, SAMURAI Study Investigators.
    Eur Neurol; 2011 May; 66(1):37-41. PubMed ID: 21709420
    [Abstract] [Full Text] [Related]

  • 27. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W.
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [Abstract] [Full Text] [Related]

  • 28. Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial.
    Phan TG, Demchuk A, Srikanth V, Silver B, Patel SC, Barber PA, Levine SR, Hill MD.
    Cerebrovasc Dis; 2013 Jun; 35(6):560-5. PubMed ID: 23838753
    [Abstract] [Full Text] [Related]

  • 29. Impact of diffusion-weighted imaging Alberta stroke program early computed tomography score on the success of endovascular reperfusion therapy.
    Inoue M, Olivot JM, Labreuche J, Mlynash M, Tai W, Albucher JF, Meseguer E, Amarenco P, Mazighi M.
    Stroke; 2014 Jul; 45(7):1992-8. PubMed ID: 24923724
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [Abstract] [Full Text] [Related]

  • 33. ASPECTS (Alberta Stroke Program Early CT Score) Assessment of the Perfusion-Diffusion Mismatch.
    Lassalle L, Turc G, Tisserand M, Charron S, Roca P, Lion S, Legrand L, Edjlali M, Naggara O, Meder JF, Mas JL, Baron JC, Oppenheim C.
    Stroke; 2016 Oct; 47(10):2553-8. PubMed ID: 27625381
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.
    Simonsen CZ, Madsen MH, Schmitz ML, Mikkelsen IK, Fisher M, Andersen G.
    Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L, Gao PY, Hu QM, Lin Y, Jing LN, Xue J, Chen ZJ, Wang YJ, Liu ML, Cai YF.
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [Abstract] [Full Text] [Related]

  • 39. Comparison of CT and DWI findings in ischemic stroke patients within 3 hours of onset.
    Mitomi M, Kimura K, Aoki J, Iguchi Y.
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):37-42. PubMed ID: 23040956
    [Abstract] [Full Text] [Related]

  • 40. The Combination of Clinical Features, Transcranial Doppler, and Alberta Stroke Program Early Computed Tomography Score (Computed Tomography Angiography) in Predicting Outcome in Intravenous Recombinant Tissue Plasminogen Activator-Treated Patients.
    Saqqur M, Ghrooda E, Ahmad A, Khan K, Hussain MS, Shuaib A.
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2019-23. PubMed ID: 27241578
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.